The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study

被引:39
|
作者
Probst-Hensch, Nicole M.
Sun, Can-Lan
Van den Berg, David
Ceschi, Michela
Koh, Woon-Puay
Yu, Mimi C.
机构
[1] Univ Zurich Hosp, Dept Mol Epidemiol, Inst Social Prevent Med Surg Pathol, CH-8091 Zurich, Switzerland
[2] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[3] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[4] Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 117597, Singapore
关键词
D O I
10.1093/carcin/bgl116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin D1 (CCND1) regulates cellular decision between proliferation and growth arrest. Despite the functional relevance of the CCND1 A870G single nucleotide polymorphism (SNP) published results on its association with colorectal cancer (CRC) were inconsistent. We examined the association between this CCND1 genotype and CRC in the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63 000 Chinese men and women. We explored the hypothesis that inconsistency regarding the CCND1/CRC association may be attributable to the modifying effect of additional CRC risk factors. Since GSTM1/GSTT1 genotype and dietary isothiocyanate (ITC) intake had previously been identified as CRC risk factors in this cohort, we now explored if they influenced the CCND1/CRC association. In a nested case-control study within the Singapore Cohort, genomic DNA collected from 300 incident CRC cases and 1169 controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 polymorphisms. Unconditional logistic regression was used to assess genotype effects on cancer risk. No main effect of CCND1 was observed, yet the CCND1 effect was influenced by ITC intake and GST genotypes. The presence of at least one CCND1 A-allele was associated with increased risk among low dietary ITC consumers (intake below median value for the cohort) with a high-activity GST profile (>= 2 of the 3 GST genotypes classified non-null or high-activity) [odds ratio (OR) = 2.05; 95% confidence interval (CI), 1.10-3.82]. In contrast, the presence of at least one A-allele was associated with a decreased risk among all remaining subjects (OR = 0.56; 0.36-0.86) (P for interaction = 0.01). Recent studies indicate that ITCs inhibit cell proliferation and cause apoptosis through pro-oxidant properties. The results of our current study on CRC and those of our previous breast cancer study are compatible with the notion of oxidative stress in target cells as important determinant of direction and magnitude of the CCND1 effect.
引用
收藏
页码:2475 / 2482
页数:8
相关论文
共 50 条
  • [1] Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
    E S Schernhammer
    G J Tranah
    E Giovannucci
    A T Chan
    J Ma
    G A Colditz
    D J Hunter
    W C Willett
    C S Fuchs
    [J]. British Journal of Cancer, 2006, 94 : 928 - 934
  • [2] The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore
    Ceschi, M
    Sun, CL
    Van Den Berg, D
    Koh, WP
    Yu, MC
    Probst-Hensch, N
    [J]. CARCINOGENESIS, 2005, 26 (08) : 1457 - 1464
  • [3] Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer
    Le Marchand, L
    Seifried, A
    Lum-Jones, A
    Donlon, T
    Wilkens, LR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (21): : 2843 - 2848
  • [4] Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients
    Forones N.M.
    De Lima J.M.
    De Souza L.G.
    Da Silva I.D.C.G.
    [J]. Journal of Gastrointestinal Cancer, 2008, 39 (1-4) : 118 - 123
  • [5] The Influence of Cyclin D1 A870G Polymorphism on Colorectal Cancer Risk and Prognosis in a Turkish Population
    Yaylim-Eraltan, Ilhan
    Arikan, Soykan
    Yildiz, Yemliha
    Cacina, Canan
    Ergen, H. Arzu
    Tuna, Gulay
    Gormus, Uzay
    Zeybek, Uemit
    Isbir, Turgay
    [J]. ANTICANCER RESEARCH, 2010, 30 (07) : 2875 - 2880
  • [6] CYCLIN D1 (A870G) GENE POLYMORPHISM IN LUNG CANCER
    Cakina, S.
    Gulyasar, T.
    Sipahi, T.
    Ozen, A.
    Kocak, Z.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S341 - S341
  • [7] A case-control study of cyclin D1 CCND1 870A→G polymorphism and bladder cancer
    Cortessis, VK
    Siegmund, K
    Xue, SY
    Ross, RK
    Yu, MC
    [J]. CARCINOGENESIS, 2003, 24 (10) : 1645 - 1650
  • [8] Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan
    Huang, Wen-Shih
    Tang, Reiping
    Lin, Paul Y.
    Changchien, Chung Rong
    Chen, Jinn-Shiun
    Chiang, Jy-Ming
    Yeh, Chien-Yuh
    Wang, Jeng-Yi
    Hsieh, Ling-Ling
    [J]. DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 602 - 608
  • [9] CCND1 G870A Polymorphism with Altered Cyclin D1 Transcripts Expression Is Associated with the Risk of Glioma in a Chinese Population
    Chen, Xiangmei
    Zhao, Tianshu
    Li, Li
    Xu, Chunhui
    Zhang, Xiaolei
    Tse, Vincent
    Zhang, Ting
    Liu, Xiaoqian
    Lu, Fengmin
    [J]. DNA AND CELL BIOLOGY, 2012, 31 (06) : 1107 - 1113
  • [10] Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism
    Catarino, R.
    Pereira, D.
    Pinto, D.
    Matos, A.
    Craveiro, R.
    Lopes, C.
    Medeiros, R.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 47 - 48